Literature DB >> 2423682

Structure-activity relationship of lidocaine homologs producing tonic and frequency-dependent impulse blockade in nerve.

P M Bokesch, C Post, G Strichartz.   

Abstract

Experiments were done to assess the relationship of the chemical properties of local anesthetics to their ability to block neuronal impulse conduction, using a series of hitherto unavailable homologs of lidocaine. These molecules varied in the number and arrangement of alkyl groups attached to the tertiary amine nitrogen. Each compound was applied to desheathed sciatic nerves of frogs (Rana pipiens) mounted in a sucrose gap recording chamber. Compound action potentials (AP) were recorded at room temperature (20-23 degrees C) and the potency of each anesthetic determined from the concentration required to produce a 40% reduction in the amplitude of the AP at low-frequency stimulation: 1 min-1. This reduction was called Bt. An additional Bt was measured from the further decrease in amplitude of the AP during high-frequency stimulation (10 and 40 Hz). Tonic and phasic blocking potencies were analyzed as functions of the calculated drug partition coefficients, and the known molecular weights, molecular configurations and pKa values. Potency for Bt increased with increasing length of n-alkyl groups attached to the terminal amine, whereas it decreased as the length of the alkyl group connecting the amide bond to the terminal amine was increased. However, when considered in terms of their physicochemical properties, the homologs showed a potency for Bt that increased uniformly with increasing partition coefficient. This analysis revealed a strong positive correlation between tonic potency and partitioning into octanol for both neutral and protonated anesthetic species but little correlation with molecular weight or pKa. However, Bt did not depend uniquely on hydrophobicity, as predicted if lipophilic partitioning alone determined potency.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423682

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels.

Authors:  D S Ragsdale; J C McPhee; T Scheuer; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

2.  Molecular basis for class Ib anti-arrhythmic inhibition of cardiac sodium channels.

Authors:  Stephan A Pless; Jason D Galpin; Adam Frankel; Christopher A Ahern
Journal:  Nat Commun       Date:  2011-06-14       Impact factor: 14.919

3.  sec-Butylpropylacetamide (SPD), a new amide derivative of valproic acid for the treatment of neuropathic and inflammatory pain.

Authors:  Dan Kaufmann; Peter J West; Misty D Smith; Boris Yagen; Meir Bialer; Marshall Devor; H Steve White; K C Brennan
Journal:  Pharmacol Res       Date:  2016-11-24       Impact factor: 7.658

4.  Potent and use-dependent block of cardiac sodium channels by U-50,488H, a benzeneacetamide kappa opioid receptor agonist.

Authors:  M K Pugsley; E J Yu; A L Goldin
Journal:  Exp Clin Cardiol       Date:  2001

5.  Anesthetics alter the physical and functional properties of the Ca-ATPase in cardiac sarcoplasmic reticulum.

Authors:  B S Karon; L M Geddis; H Kutchai; D D Thomas
Journal:  Biophys J       Date:  1995-03       Impact factor: 4.033

6.  Combined effects of different class I antiarrhythmic agents on maximum rate of depolarization (Vmax) of action potentials in guinea-pig papillary muscles.

Authors:  M Hiraoka; J Nitta; A Sunami; T Sawanobori
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

7.  Amine blockers of the cytoplasmic mouth of sodium channels: a small structural change can abolish voltage dependence.

Authors:  G W Zamponi; R J French
Journal:  Biophys J       Date:  1994-09       Impact factor: 4.033

8.  The solution conformations of lidocaine analogues.

Authors:  P D McMaster; V J Noris; C E Stankard; E W Byrnes; P R Guzzo
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

9.  Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.

Authors:  Sandra Fredj; Kevin J Sampson; Huajun Liu; Robert S Kass
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

10.  Molecular and structural basis of resting and use-dependent block of sodium current defined using disopyramide analogues.

Authors:  J Z Yeh; R E TenEick
Journal:  Biophys J       Date:  1987-01       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.